RxDoctor Payments Data

Peter Cobb, MD

Family Medicine · Smyrna, TNNPI 1336134501

Payments from drug & device makers

$10,655in general payments, 2019–2025

Across 632 payments — averaging $16.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$1K
  • AstraZeneca$837
  • Pfizer$721
  • GSK$546
  • Amgen$507
  • plus $6K from 54 others

What the payments were for

  • Food & beverage$10,55999%
  • Education$951%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)68$1,163
Novo Nordisk78$1,102
AstraZeneca(2 entities)40$837
Pfizer44$721
GSK32$546
Amgen32$507
Boehringer Ingelheim31$481
Otsuka America Pharmaceutical, Inc.23$477
Lilly USA, LLC28$434
Takeda Pharmaceuticals U.S.A., Inc.28$416
Astellas Pharma US Inc16$377
Johnson & Johnson19$331
Bayer14$235
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC14$224
Exact Sciences13$201
Novartis11$192
Merck14$190
Nestle Healthcare Nutrition Inc.10$184
Dexcom, Inc.8$140
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)7$133
Dynavax Technologies Corporation7$124
Axsome Therapeutics, Inc.6$118
Biohaven Pharmaceutical Holding Company Ltd.6$118
Amarin Pharma, Inc.6$94
Eisai Inc.6$94
Phathom Pharmaceuticals, Inc.4$73
Sanofi-aventis U.S. LLC5$69
Sumitomo Pharma America, Inc.4$66
Lundbeck LLC4$64
Aimmune Therapeutics, Inc.4$63
Shield Therapeutics Inc2$61
Shire North American Group Inc3$57
E.r. Squibb & Sons, L.L.C.4$57
Edwards Lifesciences1$53
Impel Pharmaceuticals Inc.3$50
Inspire Medical Systems, Inc.2$43
Boston Scientific2$40
Gilead2$38
Esperion Therapeutics, Inc.2$37
Antares Pharma, Inc.2$33
VBI Vaccine (delaware) Inc.2$33
Cranial Technologies, Inc1$30
Currax Pharmaceuticals LLC2$28
Xeris Pharmaceuticals, Inc.2$28
Nalpropion Pharmaceuticals LLC2$28
Idorsia Pharmaceuticals US Inc2$27
Hologic Sales And Service, LLC1$27
Adlon Therapeutics L.p.2$23
Hikma Pharmaceuticals USA1$19
Biohaven Pharmaceuticals, Inc.1$18
Insulet Corporation1$16
Daiichi Sankyo Inc.1$16
Sanofi Pasteur Inc.1$16
IBSA Pharma Inc.1$15
Ironwood Pharmaceuticals, Inc1$15
Avion Pharmaceuticals1$13
Teva Pharmaceuticals USA, Inc.1$13
Radius Health, Inc.1$12
Supernus Pharmaceuticals, Inc.1$12
Duchesnay USA Incorporated1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,655 in reported general payments places this provider in the 90th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$73,141
Medicare patients
173
Services billed
812

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin62$82,256
OzempicSemaglutide32$55,643
JanuviaSitagliptin Phosphate37$43,619
XareltoRivaroxaban25$39,333
EliquisApixaban31$37,099
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$20,554
FarxigaDapagliflozin Propanediol13$17,362
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr14$11,767
Lantus SolostarInsulin Glargine,hum.Rec.Anlog34$6,534
Atorvastatin Calcium319$4,462
Ezetimibe157$4,124
Rosuvastatin Calcium299$3,904
Omeprazole236$3,575
LantusInsulin Glargine,hum.Rec.Anlog37$3,197
Levothyroxine Sodium344$2,860

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$481$82,25662 claims
Novo NordiskOzempic$1,102$55,64332 claims
MerckJanuvia$190$43,61937 claims
Johnson & JohnsonXarelto$331$39,33325 claims
PfizerEliquis$721$37,09931 claims
GSKTrelegy Ellipta, Anoro Ellipta$546$32,32129 claims
AstraZenecaFarxiga$837$17,36213 claims
Sanofi-aventis U.S. LLCLantus$69$3,19737 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Smyrna

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →